|
시장보고서
상품코드
2075416
어린선(Fish Skin Disease) 시장 : 유형별, 치료법별, 투여 경로별, 유통 채널별, 지역별Fish Skin Disease Market, By Type, By Treatment type, By Route of Administration, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
어린선(Fish Skin Disease) 시장은 2026년에 18억 6,000만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 36억 2,000만 달러에 달할 것으로 전망되고 있습니다. 2026-2033년에는 CAGR 10.0%로 성장할 것으로 예측됩니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 18억 6,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 10.00% | 2033년 시장 규모 예측 : | 36억 2,000만 달러 |
어린선(Ichthyosis)은 광범위한 부위에 두껍고 건조한, 마치 물고기 비늘 같은 피부 증상이 지속적으로 나타나는 질환입니다. 이는 피부가 건조해지고 가려움을 동반하며, 비늘 모양으로 거칠고 붉은 기를 띠는 일련의 피부 질환을 통칭하는 용어입니다. 증상은 경증에서 중증까지 다양합니다. 어비늘진은 피부에만 영향을 미치는 경우도 있지만, 일부 유형에서는 내장에도 영향을 미칠 수 있습니다. 어린선에는 20유형 이상의 서로 다른 유형이 있습니다. 선천적으로 유전되는 유형도 있고, 성인기에 발병하는 유형도 있습니다. 치료를 통해 피부의 발적, 비늘의 두께, 가려움을 완화할 수 있습니다.
시장 역학 :
어린선(Fish Skin Disease)의 유병률 증가, 사람들의 인식 제고, 안전하고 효과적인 치료법 및 요법에 대한 수요 증가, 그리고 시장 참여자들의 새로운 치료법 및 요법 도입이 전 세계 어린선(Fish Skin Disease) 시장의 성장을 촉진할 것으로 예상되는 주요 요인입니다.
예를 들어 2023년 4월, 어피를 원료로 하는 치료 제품 제조사인 케레시스(Kerecis)사는 자사의 어피 이식편과 실리콘 접촉층을 결합하여 만성적이고 복잡한 상처를 치료하는 솔루션 ‘MariGen Shield'의 발매를 발표했습니다. 이 실리콘 접촉층은 원형 이식편을 제자리에 고정하고, 육아 조직이 형성되는 상처를 보호하는 데 도움이 됩니다.
또한 2021년 10월, Kerecis사는 'Omega3 SurgiBind'에 대해 미국 식품의약국(FDA)으로부터 판매 승인을 획득했습니다. 이 제품은 성형외과 및 재건외과에서 사용하기 위한 이식형 어피 이식임베디드니다. 성형외과 또는 재건외과에서, 연부 조직의 복구나 보강이 필요한 환자의 취약한 연부 조직을 강화하기 위한 적응증이 있습니다.
본 조사의 주요 특징 :
- 이 조사에서는 다양한 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하고 있는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 이 조사에서는 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 지표를 바탕으로 전 세계 어피 이식 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 등급 향상, 시장 확대 및 마케팅 전략에 관해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 이 '세계의 어린선(Fish Skin Disease) 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 어린선(Fish Skin Disease) 시장 분석에 활용된 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 어린선(Fish Skin Disease)
제5장 어린선(Fish Skin Disease) 시장 : 유형별, 2021-2033년
제6장 어린선(Fish Skin Disease) 시장 : 치료 유형별, 2021-2033년
제7장 어린선(Fish Skin Disease) 시장 : 투여 경로별, 2021-2033년
제8장 어린선(Fish Skin Disease) 시장 : 유통 채널별, 2021-2033년
제9장 어린선(Fish Skin Disease) 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 섹션
KSA 26.07.08Fish Skin Disease Market is estimated to be valued at USD 1.86 Bn in 2026 and is expected to reach USD 3.62 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1.86 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.00% | 2033 Value Projection: | USD 3.62 Bn |
Ichthyosis is a medical condition that causes widespread and persistent thick, dry, fish-scale skin. It is a group of skin disorders that lead to dry and itchy skin that appears scaly, rough, and red. The symptoms can range from mild to severe. Ichthyosis can affect only the skin, but some forms of the disease can affect internal organs as well. There are more than 20 different types of ichthyosis. Some types are inherited at birth, and others are acquired during adulthood. The treatment helps reduce the redness of the skin, thickness of the scales, and itching.
Market Dynamics:
The rise in burden of fish skin disease, the rise in awareness among people, the increase in demand for safe, effective treatments & therapies, and the introduction of novel treatments and therapies by market players are major factors expected to propel growth of the global fish skin disease market.
For instance, in April 2023, Kerecis, a manufacturer of fish skin-based therapeutic products announced the launch of the MariGen Shield, a solution that combines the company's fish-skin graft and a silicone contact layer to treat chronic and complex wounds. The silicone contact layer anchors the round graft in position and help safeguard granulating wound
Moreover, in October 2021, Kerecis received the U.S. Food and Drug Administration (FDA) marketing authorization for Omega3 SurgiBind. It is an implantable fish-skin graft intended for use in plastic and reconstructive surgery. It is indicated for strengthening weak soft tissue in patients who require soft tissue repair or reinforcement in plastic or reconstructive surgery.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global fish skin disease market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include GSK Plc., AbbVie Inc., Sonnet BioTherapeutics, Krystal Biotech, LEO Pharma, GALDERMA, GLENMARK PHARMACEUTICALS LTD., Mayne Pharma Group Limited, Ortho Dermatologics, Cellegy Pharmaceuticals, Patagonia Pharmaceuticals, LLC, Crown Laboratories, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global fish skin disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fish skin disease market
Fish Skin Disease Market Detailed Segmentation:
- By Type (Revenue, USD Bn, 2021 - 2033):
- Ichthyosis vulgaris
- X-linked recessive ichthyosis
- Others (Autosomal recessive congenital ichthyosis, etc.)
- By Treatment Type (Revenue, USD Bn, 2021 - 2033)
- Corticosteroids
- Emollients
- Retinoids
- Others (Keratolytics, etc.)
- By Route of Administration (Revenue, USD Bn, 2021 - 2033)
- Topical
- Oral
- Parenteral
- By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- GSK Plc.
- AbbVie Inc.
- Sonnet BioTherapeutics
- Krystal Biotech
- LEO Pharma
- GALDERMA
- GLENMARK PHARMACEUTICALS LTD.
- Mayne Pharma Group Limited
- Ortho Dermatologics
- Cellegy Pharmaceuticals
- Patagonia Pharmaceuticals, LLC
- Crown Laboratories, Inc.
Table of Contents:
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Fish Skin Disease, By Type
- Market Fish Skin Disease, By Treatment Type
- Market Fish Skin Disease, By Route of Administration
- Market Fish Skin Disease, By Distribution Channel
- Market Fish Skin Disease, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rise in burden of fish skin disease across the globe
- Lack of awareness among people
- Increase in demand for safe and effective treatments/therapies
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER€(TM)s Analysis
- Merger and Acquisition Scenario
4. Fish Skin Disease
- Supply Side and Demand Side Analysis
- Economic Impact
5. Fish Skin Disease Market, By Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Ichthyosis vulgaris
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033,(US$ Bn)
- X-linked recessive ichthyosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033,(US$ Bn)
- Others (Autosomal recessive congenital ichthyosis, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033,(US$ Bn)
6. Fish Skin Disease Market, By Treatment Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033,(US$ Bn)
- Emollients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033,(US$ Bn)
- Retinoids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033,(US$ Bn)
- Others (Keratolytics, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033,(US$ Bn)
7. Fish Skin Disease Market, By Route of Administration, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
8. Fish Skin Disease Market, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
9. Fish Skin Disease Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 €"2033, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Bn)
- India
- China
- Japan
- Australia
- ASEAN
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- GSK Plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sonnet BioTherapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Krystal Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LEO Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GALDERMA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GLENMARK PHARMACEUTICALS LTD.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mayne Pharma Group Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ortho Dermatologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cellegy Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Patagonia Pharmaceuticals, LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Crown Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
11. Section
- Research Methodology
- About us
